Bacterial Infections: Bacterial Contamination, Testing, and Post-Transfusion Complications

Blood Banking and Transfusion Medicine

Volumn , Issue , 2007, Pages 639-651

  Ramírez Arcos, Sandra M ^a   Goldman, Mindy ^b   Blajchman, Morris A ^b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c Hamilton Regional Laboratory Program   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882501890     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06981-9.50052-1     Document Type: Chapter

References (133)

1. Yomtovian R, Palavecino E Bacterial contamination of blood components-history and epidemiology. Bacterial and Parasitic Contamination of Blood Components 2003, 1-30. American Association of Blood Banks, Bethesda, Md. M.E. Brecher (Ed.).
2. Brecher ME, Hay SN Bacterial contamination of blood components. Clin Microbiol Rev 2005, 18:195-204.
3. Blajchman MA, Beckers EAM, Dickmeiss E, et al. Bacterial detection of platelets: Current problems and possible resolutions. Transfus Med Rev 2005, 19:259-272.
4. Kleinman S, Chan P, Robillard P Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 2003, 17:120-162.
5. Boulton FE, Chapman ST, Walsh TH Fatal reaction to transfusion of red-cell concentrate contaminated with Serratia liquefaciens. Transfus Med 1998, 8:15-18.
6. McDonald CP, Hartley S, Orchard K, et al. Fatal Clostridium per-fringens sepsis from a pooled platelet transfusion. Transfus Med 1998, 8:19-22.
7. Theakston EP, Morris AJ, Streat SJ, et al. Transfusion-transmitted Yersinia enterocolitica infection in New Zealand. Aust NZ J Med 1997, 127:62-67.
8. Red blood cell transfusions contaminated with Yersinia enterocolitica-United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR Morb Mortal Wkly Rep 1997, 46:553-555. Centers for Disease Control and Prevention.
9. Morrow JF, Braine HG, Kickler TS, et al. Septic reactions to platelet transfusions. JAMA 1991, 266:555-558.
10. Blajchman MA, Ali AM Bacteria in the blood supply: an overlooked issue in transfusion medicine. Blood Safety: Current Challenges 1992, 213-228. American Association of Blood Banks, Bethesda, Md. S.J. Nance (Ed.).
11. Barrett BB, Anderson JW, Anderson KC Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993, 33:228-233.
12. Yomtovian R, Lazarus HM, Goodnough LT, et al. A prospective micro-biologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993, 33:902-909.
13. Chiu EKW, Yuen KY, Lie AKW, et al. A prospective study on symptomatic bacteremia from platelet transfusion and its management. Transfusion 1994, 34:950-965.
14. Dzieczkowski JS, Barrett BB, Nester D, et al. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Transfusion 1995, 35:20-25.
15. Blajchman MA, Ali A, Lyn P, et al., A prospective study to determine the frequency of bacterial contamination in random donor platelet concentrates [Abstract]. Blood 1994;84S:529a.
16. Leiby DA, Kerr KL, Compos JM, et al. A prospective analysis of micro-bial contaminants in outdated random-donor platelets from multiple sites. Transfusion 1997, 37:259-263.
17. Blajchman MA, Ali A, Lyn P, et al. Bacterial surveillance of platelet concentrates: Quantitation of bacterial load [Abstract]. Transfusion 1997, 37(Suppl):74S.
18. Liu H, Yuen K, Cheng T, et al. Reduction of platelet transfusion-associated sepsis by short-term bacterial culture. Vox Sang 1999, 77:1-5.
19. Goldman M, Blajchman MA Blood product-associated bacterial sepsis. Transfus Med Rev 1991, 5:73-83.
20. Goldman M, Lee J-H, Blajchman M Skin antisepsis and initial aliquot diversion. Bacterial and Parasitic Contamination of Blood Components 2003, 31-56. American Association of Blood Banks, Bethesda, Md. M.E. Brecher (Ed.).
21. Richards C, Kolins J, Trindale CD Autologous transfusion-transmitted Yersinia enterocolitica [Letter]. JAMA 1992, 268:1541-1542.
22. Sire JM, Michelet C, Mesnard R, et al. Septic shock due to Yersinia enterocolitica after autologous transfusion [Letter]. Clin Infect Dis 1993, 17:954-955.
23. Duncan KL, Ransley J, Elterman M Transfusion-transmitted Serra-tia liquefaciens from an autologous blood unit [Letter]. Transfusion 1994, 34:738-739.
24. Haditsch M, Binder L, Gabriel C, et al. Yersinia enterocolitica septice-mia in autologous blood transfusion. Transfusion 1994, 34:907-909.
25. Mitchell KMT, Brecher ME Approaches to the detection of bacterial contamination in cellular blood products. Transfus Med Rev 1999, 13:132-144.
26. Blajchman MA, Goldman M, Baeza F Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 2004, 18:11-24.
27. Perez-Pujol A, Tonda R, Lozano B, et al. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion 2005, 45:911-919.
28. Allain JP, Bianco C, Blajchman MA, et al. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Med Rev 2005, 19:110-126.
29. Goldman M, Blajchman MA Bacterial contamination. Transfusion Reactions 2001, 129-154. American Association of Blood Banks, Bethesda, Md. 2nd ed. M. Popovsky (Ed.).
30. McAllister SK, Bland LA, Arduino MJ, et al. Patient cytokine response in transfusion-associated sepsis. Infect Immun 1994, 62:2126-2128.
31. Schwalbe B, Späth-Schwalbe E Endotoxin concentrations and cytokine responses in a patient with fatal transfusion-associated sepsis [Letter]. Transfusion 1998, 38:703-705.
32. de Korte D Implementation of a screening system for bacterial detection. Bacterial and Parasitic Contamination of Blood Components 2003, 83-105. American Association of Blood Banks, Bethesda, Md. M.E. Brecher (Ed.).
33. Olsen KE, Sandler SG Febrile neutropenia contributes to underreporting of potential septic platelet transfusion reactions [Letter]. Vox Sang 1996, 70:118.
34. Zaza S, Tokars JI, Yomtovian R, et al. Bacterial contamination of platelets at a university hospital: Increased identification due to intensified surveillance. Infect Control Hosp Epidemiol 1994, 15:82-87.
35. Hillyer CD, Josephson CD, Blajchman MA, et al., Bacterial contamination of blood components: Risks, strategies, and regulation. Joint ASH and AABB educational session in transfusion medicine. Hematology 2003:575-589.
36. Rhame FS, McCullough J Follow-up on nosocomial Pseudomonas cepacia infection. MMWR Morb Mortal Wkly Rep 1979, 28:409.
37. Casewell MW, Slater NGP, Cooper JE Operating theatre water-baths as a cause of Pseudomonas septicaemia. J Hosp Infect 1981, 2:237-240.
38. Attarian H, Bensinger WI, Buckner CD, et al. Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 1996, 17:699-702.
39. Kamble R, Pant S, Selby GB, et al. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts. Transfusion 2005, 45:874-878.
40. Aber RC Transfusion-associated Yersinia enterocolitica. Transfusion 1990, 30:193-195.
41. Mitchell R, Barr A Transfusing Yersinia enterocolitica [Letter]. BMJ 1992, 305:1095-1096.
42. Beresford AM Transfusion reaction due to Yersinia enterocolitica and review of other reported cases. Pathology 1995, 27:133-135.
43. Leclercq A, Martin L, Vergnes ML, et al. Fatal Yersinia enterocolitica biotype 4 serovar O:3 sepsis after red blood cell transfusion. Transfusion 2005, 45:814-818.
44. Arduino MJ, Bland LA, Tipple MA, et al. Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes. J Clin Microbiol 1989, 27:1483-1485.
45. Roth VR, Arduino MJ, Nobiletti SC, et al. Transfusion-related sepsis due to Serratia liquefaciens in the United States. Transfusion 2000, 40:931-935.
46. Shimbun Y. 80 likely contracted diseases via tainted blood since April. The Daily Yomiuri. Available at. Accessed Sept. 30, 2005. http://www.yomiuri.co.jp/newse/20040812wo32.htm.
47. Benfell C. Unusual bacteria blamed for blood transfusion death. Circulator 2004;Fall:2. Available at. Accessed Sept. 30, 2005. http://chapters.redcross.org/ca/norcal/phys/pdf/Circulator_Oct2004.pdf.
48. Chang AH, Kirsch CM, Mobashery N, et al. Streptococcus bovis septic shock due to contaminated transfused platelets. Am J Hematol 2004, 77:282-286.
49. Haimowitz MD, Hernandez LA, Herron RM A blood donor with bacteremia. Lancet 2005, 365:1596.
50. Arendt A, Carmean J, Koch E, et al. Fatal bacteria infections associated with platelet transfusions-United States, 2004. MMWR Morb Mortal Wkly Rep 2005, 54:168-170.
51. Rhame FS, Root RK, MacLowry JD, et al. Salmonella septicemia from platelet transfusions: study of an outbreak traced to a hema-togeneous carrier of Salmonella choleraesius. Ann Intern Med 1973, 78:633-641.
52. Wang SA, Tokars JI, Bianchine PJ, et al. Enterobacter cloacae bloodstream infections traced to contaminated human albumin. Clin Infect Dis 2000, 30:35-40.
53. Arguin PM, Singleton J, Rotz LD, et al. An investigation into the possibility of transmission of tick-borne pathogens via blood transfusion. Transfusion 1999, 39:828-833.
54. Casleton BG, Salata K, Dasch GA, et al. Recovery and viability of Ori-entia tsutsugamushi from packed red cells and the danger of acquiring scrub typhus from blood transfusion. Transfusion 1998, 38:680-689.
55. Badon SJ, Fister RD, Cable RG Survival of Borrelia burgdorferi in blood products. Transfusion 1989, 29:581-583.
56. Goodman JL, Bradley JF, Ross AE, et al. Bloodstream invasion in early Lyme disease: Results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med 1995, 99:6-12.
57. Aoki SK, Holland PV Lyme disease: another transfusion risk?. Transfusion 1989, 29:646-650.
58. Lyme disease-United States, 1996. MMWR Morb Mortal Wkly Rep 1997, 46:531-535. Centers for Disease Control and Prevention.
59. Halkier-Sorensen L, Kragballe K, Nedergaard St, et al. Lack of transmission of Borrelia burgdorferi by blood transfusion [Letter]. Lancet 1990, 1:550.
60. Cable R, Krause P, Badon S, et al. Acute blood donor co-infection with Babesia microti [Abstract]. Transfusion 1993, 33(Suppl):50S.
61. Gerber MA, Shapiro ED, Krause PJ, et al. The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis 1994, 170:231-234.
62. Gibson T, Norris W Skin fragments removed by injection needles. Lancet 1958, 2:983-985.
63. Anderson KC, Lew MA, Gorgone BC, et al. Transfusion-related sepsis after prolonged platelet storage. Am J Med 1986, 81:405-411.
64. Mase K, Hasegawa T, Horii T, et al. Firm adherence of Staphylococcus aureus and Staphylococcus epidermidis to human hair and effect of detergent treatment. Microbiol Immunol 2000, 44:653-656.
65. Jafari M, Forsberg J, Gilcher RO, et al. Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake. NEJM 2002, 347:1075-1078.
66. Blajchman MA, Thornley JH, Richardson H, et al. Platelet transfusion-induced Serratia marcescens sepsis due to vacuum tube contamination. Transfusion 1979, 19:39-44.
67. Kosmin M Bacteremia during leukapheresis [Letter]. Transfusion 1980, 20:115.
68. Chaffin DJ Pseudomonas fluorescens-related septic transfusion reaction resulting from contaminated cold cloths. [Abstract]. Transfusion 2002, 42(Suppl):41S.
69. Heltberg O, Skov F, Gerner-Smidt P, et al. Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion 1993, 33:221-227.
70. Högman CF, Fritz H, Sandberg L Posttransfusion Serratia marcescens septicemia [Editorial]. Transfusion 1993, 33:189-191.
71. Högman CF, Engstrand L Serious bacterial complications from blood components: How do they occur?. Transfus Med 1998, 8:1-3.
72. Dyer O Blood authority investigates faulty blood bags. BMJ 1995, 311:145.
73. Steere AC, Terrey JH, Mackel DC, et al. Pseudomonas species bacteremia caused by contaminated normal human serum albumin. J Infect Dis 1977, 135:729-735.
74. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001, 41:1493-1499.
75. Noel L, Debeir J, Cosson A The French haemovigilance system. Vox Sang 1998, 74(Suppl 2):441-445.
76. Perez P, Ngombet R, Debeir J, et al. Les incidents transfusionnels par contamination bactérienne: synthèse de la littérature et des données d'hémovigilance. Transfus Clin Biol 1998, 5:203-210.
77. Noël L, Audurier A Contaminations bactériennes des produits sanguins labiles [Abstract]. Transfus Clin Biol 1998, 5(Suppl 1):256S.
78. Perez P, Salmi LR, Follea G, et al. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM case-control study. Transfusion 2001, 41:862-871.
79. Williamson LW, Love EM Reporting serious hazards of transfusion: The SHOT program. Transfus Med Rev 1998, 12:28-35.
80. Serious Hazards of Transfusion (SHOT). Summary of annual report 2003. Available at. Accessed Sept. 30, 2005. http://www.shotuk.org/SHOT%20Report%202003.pdf.
81. MacDonald N Transfusion and risk infection in Canada: Update 2005. Paediatr Child Health 2005, 10:149-153.
82. Robillard P, Nawej KI Four-year trends in the incidence of bacterial contaminations in the Quebec hemovigilance system. [Abstract]. Transfusion 2004, 44(Suppl):19A.
83. Grossman BJ, Kollins P, Lau PM, et al. Screening blood donors for gastrointestinal illness: a strategy to eliminate carriers of Yersinia enterocolitica. Transfusion 1991, 31:500-501.
84. Ness PM, Perkins HA Transient bacteremia after dental procedures and other minor manipulations. Transfusion 1980, 20:82-85.
85. Goldman M, Long A, Roy G, et al. Incidence of positive bacterial cultures after donor call-back [Letter]. Transfusion 1996, 36:1035.
86. AABB News Briefs 1989, 12:1-4.
87. Goldman M, Roy G, Fréchette N, et al. Evaluation of donor skin disinfection methods. Transfusion 1997, 37:309-312.
88. Kitchen AD, Howe PHJ Donor arm swabbing: how clean is clean? [Abstract]. Transfus Med 1995, 5(Suppl):50.
89. Goldman M Challenges in developing a bacterial detection system. Vox Sang 2002, 83(Suppl 1):125-127.
90. Wagner SJ, Moroff G, Katz AJ, Friedman LI Comparison of bacteria growth in single and pooled platelet concentrates after deliberate inoculation and storage. Transfusion 1995, 35:298-302.
91. Brumit MC, Hay SN, Brecher ME Bacteria detection. Bacterial and Parasitic Contamination of Blood Components 2003, 57-81. American Association of Blood Banks, Bethesda, Md. M.E. Brecher (Ed.).
92. Brecher ME, Hay SN, Rothenberg SJ Validation of BacT/ALERT plastic culture bottles for use in testing of whole-blood-derived leukore-duced platelet-rich-plasma-derived platelets. Transfusion 2004, 44:1174-1178.
93. Brecher ME, Heath DG, Hay SN, et al. Evaluation of a new generation of culture bottle using an automated bacterial culture system for detecting nine common contaminating organisms found in platelet components. Transfusion 2002, 42:774-779.
94. Chambers LA Initial results of culturing apheresis platelets to detect bacterial contamination [Abstract]. Transfusion 2004, 44(Suppl):19A.
95. Fayed R, Taylor C, Linauts S Evaluation of BacT/ALERT 3D signature in a blood bank setting, one-year anniversary. [Abstract]. Transfusion 2004, 44(Suppl):52A.
96. Jacobson JL, Strauss DL, O'Brien TC, et al. Quality control testing using the BacT/ALERT on apheresis platelet collections to reduce the risk of transfusion-transmitted bacterial sepsis [Abstract]. Transfusion 2004, 44(Suppl):20A.
97. Rios JA, Norton J, Benjamin RJ Bacterial testing of platelets pheresis using BacT/ALERT [Abstract]. Transfusion 2004, 44(Suppl):52A.
98. Peck KB, Horn KD, Tegtmeier GE, et al. Bacterial testing of platelets pheresis using BacT/ALERT [Abstract]. Transfusion 2004, 44(Suppl):53A.
99. Goldman M, Delage G. Culturing of apheresis platelets-CBS and Héma-Québec experience. 2005 Joint Conference of the CSTM, CBS, and Héma-Québec. 21-24 April 2005, Banff, AB, Canada.
100. Larsen CP, Ezligini F, Hermansen NO, et al. Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005, 88:93-97.
101. Liu HW, Yuen KY, Cheng TS, et al. Reduction of platelet transfusion-associated sepsis by short-term bacterial culture. Vox Sang 1999, 77:1-5.
102. Lee CK, Ho PL, Lee KY, et al. Estimation of bacterial risk in extending the shelf life of PLT concentrates from 5 to 7 days. Transfusion 2003, 43:1047-1052.
103. Ramirez-Arcos S, Goldman M Evaluation of pooled cultures for bacterial detection in whole blood-derived platelets. Transfusion 2005, 45:1275-1279.
104. Malone T, Williams D, Leparc GF Routine bacterial culture of apheresis and whole blood-derived platelets: regional blood centre experience. [Abstract]. Transfusion 2004, 44(Suppl):170A.
105. te Boekhorst PA, Beckers EA, Vos MC, et al. Clinical significance of bacte-riologic screening in platelet concentrates. Transfusion 2005, 45:514-519.
106. FDA Center for Biologics Evaluation and Research, March 2005. Available at. Accessed Sept. 30, 2005. http://www.fda.gov/cber/510ksumm/k040086s.htm.
107. Rock G, Neurath D, Cober N, et al. Seven-day storage of random donor PLT concentrates. Transfusion 2003, 43:1374-1377.
108. Ortolano GA, Freundlich LF, Holme S, et al. Detection of bacteria in WBC-reduced PLT concentrates using percent oxygen as a marker for bacteria growth. Transfusion 2003, 43:1276-1285.
109. Holme S, McAlister MB, Ortolano GA, et al. Enhancement of a culture-based bacterial detection system (eBDS) for platelet products based on measurement of oxygen consumption. Transfusion 2005, 45:984-993.
110. Nguyen K-A T, Yamamoto T, Svoboda R, et al. Clinical performance of the Pall BDS bacterial detection system: one year's experience in a blood center setting [Abstract]. Transfusion 2004, 44(Suppl):20A.
111. Yu JC, Chong C, Cortus MA, et al. Bacteria growth in leukoreduced AS-3 red cell concentrates (RCC) and detection with PALL Ebds [Abstract]. Transfusion 2004, 44(Suppl):45A.
112. Jacobs MR, Bajaksouzian S, Windau A, et al. Evaluation of the Scan-system method for detection of bacterially contaminated platelets. Transfusion 2005, 45:265-269.
113. McDonald CP, Colvin J, Robbins S, et al. Use of a solid-phase fluorescent cytometric technique for the detection of bacteria in platelet concentrates. Transfus Med 2005, 15:175-183.
114. Ribault S, Faucon A, Grave L, et al. Detection of bacteria in red blood cell concentrates by the Scansystem method. J Clin Microbiol 2005, 43:2251-2255.
115. Yazer MH, Triulzi DJ Use of a pH meter for bacterial screening of whole blood platelets. Transfusion 2005, 45:1133-1137.
116. Dreier J, Stormer M, Kleesiek K Tw o novel real-time reverse tran-scriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates. J Clin Microbiol 2004, 42:4759-4764.
117. Mohammadi T, Pietersz RN, Vandenbroucke-Grauls CM Detection of bacteria in platelet concentrates: comparison of broad-range real-time 16S rDNA polymerase chain reaction and automated culturing. Transfusion 2005, 45:731-736.
118. Engen T, Refseth U, Kleveland E, et al., Evaluation of a novel method for detection of bacterial contamination of platelet concentrates. [Abstract]. ASM General Meeting, New Orleans, La., 2004.
119. Yomtovian R Bacterial contaminaton of blood: Lessons from the past and road map for the future. Transfusion 2004, 44:450-460.
120. Ness PM, Campbell-Lee SA Single donor versus pooled random donor platelet concentrates. Curr Opin Hematol 2001, 8:392-396.
121. Högman CF, Gong J, Eriksson L, et al. White cells protect donor blood against bacterial contamination. Transfusion 1991, 31:620-626.
122. Goldman M, Delage G The role of leukodepletion in the control of transfusion-transmitted disease. Transfus Med Rev 1995, 9:9-19.
123. Heal JM, Cohen HJ Do white cells in stored blood component reduce the likelihood of posttransfusion bacterial sepsis? [Editorial]. Transfusion 1991, 31:581-583.
124. Reesink HW, Hanfland P, Hertfelder H, et al. International forum: what is the optimal storage temperature for whole blood prior to preparation of blood components?. Vox Sang 1993, 65:320-327.
125. Pietersz RNI, Reesink HW, Dekker MA, et al. Elimination of Yersinia enterocolitica by a 20h hold of whole blood and removal of leukocytes by filtration [Abstract]. Transfusion 1992, 32(Suppl):66S.
126. Wagner S, Moroff G, Katz A, Friedman L Bacterial levels in components, prepared from deliberately inoculated whole blood held for 8 and 24 hours at room temperature [Abstract]. Transfusion 1994, 34(Suppl):9S.
127. Hoffmeister KM, Josefsson EC, Isaac NA, et al. Glycosylation restores survival of chilled blood platelets. Science 2003, 301:1457.
128. Nie Y, de Pablo JJ, Palecek SP Platelet cryopreservation using a treha-lose and phosphate formulation. Biotechnol Bioeng 2005, 92:79-90.
129. Bradley RM, Gander RM, Patel SK, et al. Inhibitory effect of 0°C storage on the proliferation of Yersinia enterocolitica in donated blood. Transfusion 1997, 37:691-695.
130. Lin L, Dikeman R, Molini B, et al. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004, 44:1496-1504.
131. AABB. Bacterial contamination of platelets: Summary for clinicians on potential management issues related to transfusion recipients and blood donors. Available at. Accessed Sept. 30, 2005. http://www.aabb.org/Pressroom/In_the_News/bactcontplat022305.htm.
132. AABB. Bulletin #04-07. Available at. Accessed Sept. 30, 2005. http://www.aabb.org/members_only/archives/association_bulletins/ab04-7.h tm.
133. AABB. Bulletin #05-02. Available at hhtp://www.aabb.org/Members_Only/Archives/Association_Bulletins/ab05-2.h tm. Accessed Sept. 30, 2005.